Your browser doesn't support javascript.
loading
Combination of CRAFITY score with Alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Teng, Wei; Lin, Chen-Chun; Su, Chung-Wei; Lin, Po-Ting; Hsieh, Yi-Chung; Chen, Wei-Ting; Ho, Ming-Mo; Wang, Ching-Ting; Chai, Pei-Mei; Hsieh, Jason Chia-Hsun; Lin, Chun-Yen; Lin, Shi-Ming.
Afiliación
  • Teng W; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taiwan.
  • Lin CC; College of Medicine, Chang Gung University Taiwan.
  • Su CW; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taiwan.
  • Lin PT; College of Medicine, Chang Gung University Taiwan.
  • Hsieh YC; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taiwan.
  • Chen WT; College of Medicine, Chang Gung University Taiwan.
  • Ho MM; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taiwan.
  • Wang CT; College of Medicine, Chang Gung University Taiwan.
  • Chai PM; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taiwan.
  • Hsieh JC; College of Medicine, Chang Gung University Taiwan.
  • Lin CY; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center Taiwan.
  • Lin SM; College of Medicine, Chang Gung University Taiwan.
Am J Cancer Res ; 12(4): 1899-1911, 2022.
Article en En | MEDLINE | ID: mdl-35530282
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos